pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jul 20·1 min read
save

Bristol Myers Squibb partners with Nvidia to build pharma's most advanced AI supercomputer

Jul 20, 2026·read at Endpoints ↗DealPositive

Bristol Myers Squibb announced it will construct what it calls the most advanced and energy-efficient AI supercomputer system in the biopharma sector.

The project will be carried out in partnership with Nvidia, leveraging the chipmaker's AI hardware and software expertise to create a platform aimed at accelerating drug discovery and development.

The initiative makes Bristol Myers Squibb the first pharmaceutical company to deploy such a high-performance AI infrastructure, underscoring its commitment to integrating cutting-edge technology into its research pipeline.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Bristol Myers, Nvidia say they'll build 'most powerful' AI supercomputer in pharma”

read at Endpoints ↗
85 words · retrieved Jul 20
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
BRISTOL4BRISTOL MYERS SQUIBB3BRISTOL MYERS SQUIBB CO3

related stories

  • May 29Bristol Myers unveils data for one of its next-gen blood cancer drugsBioPharma Dive
  • May 29Replimune takes third swing at cancer drug approval following ‘productive’ FDA talksBioPharma Dive
  • May 29Pfizer, Innovent strike $10B cancer drug dealBioPharma Dive
  • May 19STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much moreSTAT
  • May 18STAT+: Supreme Court rejects challenge to Medicare drug price negotiationSTAT